4.4 Article

Vancomycin-Resistant Enterococci in Long-Term Care Facilities

Journal

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 30, Issue 8, Pages 786-789

Publisher

UNIV CHICAGO PRESS
DOI: 10.1086/598345

Keywords

-

Funding

  1. Pfizer pharmaceutical company

Ask authors/readers for more resources

Knowledge of the prevalence rates and associated risk markers of vancomycin-resistant enterococci (VRE) colonization among long-term care facility (LTCF) residents could be used to improve screening policies among newly admitted hospital inpatients. In a cross-sectional survey among 1,215 residents of LTCFs in Jerusalem, the VRE carriage rate was 9.6%. Previous hospitalization and antibiotic treatment were associated with elevated VRE colonization rate. In contrast, moderate and severe levels of dependency and prolonged stay in an LTCF were associated with a decrease in the VRE colonization rate.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available